Israel - inglés - Ministry of Health

megapharm ltd - mesna - solution for injection - mesna 400 mg/vial - mesna - prevention of urinary passage toxicity of oxazaphosphorines (ifosfamide ,cyclophosphamide, trofosamide), in particular in high-risk patients with previous radiation therapy in the area of the lesser pelvis, cystitis with previous ifosfamide, cyclophosphamide or trofosamide , urinary passage diseases in anamnesis.

Kenia - inglés - Pharmacy and Poisons Board

getwell pharmaceuticals ltd 474, udyog vihar, phase-v, gurugram- 122016, - ifosfamide usp and mesna bp - powder for injection - 2gm of sterile ifosfamide usp and mesna bp… - combinations of antineoplastic agents

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - mesna - solution for injection/infusion - 100 milligram(s)/millilitre - detoxifying agents for antineoplastic treatment; mesna

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - mesna 100 mg/ml;   - solution for injection - 100 mg/ml - active: mesna 100 mg/ml   excipient: disodium edetate dihydrate sodium hydroxide water for injection - for the prophylaxis of haematuria and haemorrhagic cystitis in patients treated with cyclophosphamide or ifosfamide in doses considered to be urotoxic. uromitexan is also indicated in at risk patients even though these patients may be receiving relatively low doses of oxazaphosphorines. at risk patients include those that have experienced previous irradiation of the small pelvis, cystitis with earlier oxazaphosphorine therapy, and/or a case history of urinary tract disease.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - mesna 600mg - film coated tablet - 600 mg - active: mesna 600mg excipient: calcium hydrogen phosphate dihydrate hypromellose lactose monohydrate macrogol 6000 magnesium stearate maize starch microcrystalline cellulose povidone simeticone titanium dioxide - for the reduction and prevention of urinary tract toxicity (haemorrhagic cystitis) of oxazaphosphorines (see adverse effects sections of the cyclophosphamide [endoxan] and ifosfamide [holoxan] data sheets).

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - mesna 400mg - tablet - 400 mg - active: mesna 400mg excipient: calcium hydrogen phosphate dihydrate hypromellose lactose monohydrate macrogol 6000 magnesium stearate maize starch microcrystalline cellulose povidone simeticone titanium dioxide - for the reduction and prevention of urinary tract toxicity (haemorrhagic cystitis) of oxazaphosphorines (see adverse effects sections of the cyclophosphamide [endoxan] and ifosfamide [holoxan] data sheets).

Bélgica - inglés - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

baxter sa-nv - mesna 400 mg/4 ml - solution for injection - 100 mg/ml - mesna 100 mg/ml - mesna

India - inglés - Central Drugs Standard Control Organization

alkem - mesna - amp - 200mg - 1

India - inglés - Central Drugs Standard Control Organization

cipla - mesna - inj - 200mg/2ml - 2ml amp.

India - inglés - Central Drugs Standard Control Organization

cytomed(alkem) - mesna - amp. - 2mg - 2ml